Tech Company Financing Transactions

DalCor Pharmaceuticals Funding Round

DalCor Pharmaceuticals, based in Sarasota, secured $150 million in investment from private investors, Sanderling Ventures and CDC - Caisse des Depots.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

677 N. Washington Blvd. 32
Sarasota, FL 34236
USA

Phone

941-306-2362

Website

www.dalcorpharma.com

Email Address

[email protected]

Overview

DalCor is focused on providing precision medicine through identification of genetically distinct patient populations that derive clinical benefits. By integrating clinical, biologic and genetic insights, DalCor intends to deliver superior outcomes in clinical medicine.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Fouzia Laghrissi-Thode

        

Chief Financial Officer

Michael Dixon

        

Chief Medical Officer

Donald Black

        

VP - Operations

Therese Heinonen

        

VP - Operations

Peter Schuepbach

        

Browse more venture capital transactions:

Prev: 4/20/2016: TrapX Security venture capital transaction
Next: 4/20/2016: PicsArt venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary